Finance

Lists
KPL:NSE
Kwality Pharmaceuticals Ltd
₹3,281.10
-2.11%
(-70.60) 1D
Sep 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for KPL...
Open
₹3,350.00
High
₹3,421.70
Low
₹3,211.10
Mkt. cap
34.05B
Avg. vol.
0.00
Volume
49.24K
P/E ratio
42.00
52-wk high
₹3,744.00
52-wk low
₹1,561.00
EPS
₹78.11
No. of employees
1K
Open
₹3,350.00
High
₹3,421.70
Low
₹3,211.10
Mkt. cap
34.05B
Avg. vol.
0.00
Volume
49.24K
P/E ratio
42.00
52-wk high
₹3,744.00
52-wk low
₹1,561.00
EPS
₹78.11
No. of employees
1K
About Kwality Pharmaceuticals Ltd
CEO-
Employees1.14K
Founded1983
Headquarters-
SectorPharmaceutical industry
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.62B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.11B
1.23B
1.57B
1.62B
Cost of goods sold
546.25M
590.97M
942.31M
874.25M
Cost of revenue
546.25M
590.97M
942.31M
874.25M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
133.13M
143.58M
174.62M
147.44M
Operating expense
351.33M
386.86M
291.65M
382.79M
Total operating expenses
897.58M
977.83M
1.23B
1.26B
Operating income
212.93M
256.56M
337.17M
366.48M
Other non operating income
-1.00K
-1.00K
2.00K
-1.00K
EBT including unusual items
184.50M
223.45M
316.68M
339.87M
EBT excluding unusual items
184.50M
231.75M
309.56M
339.87M
Income tax expense
43.35M
63.45M
63.58M
83.65M
Effective tax rate
23.49%
28.40%
20.08%
24.61%
Other operating expenses
168.61M
195.06M
64.39M
185.41M
Net income
141.16M
160.09M
253.01M
256.24M
Net profit margin
12.71%
12.97%
16.10%
15.78%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.25M
-
Interest expense
-28.42M
-24.82M
-28.87M
-26.61M
Net interest expenses
-28.42M
-24.82M
-27.61M
-26.61M
Depreciation and amortization charges
49.60M
48.22M
52.64M
49.95M
EBITDA
261.55M
302.29M
386.70M
416.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps